Court Opinion

ID: 7797659
Source: CourtListenerOpinion
Date Created: 2022-08-03 21:00:53.339324+00
Date Added: 2024-06-11T16:28:40.440329
License: Public Domain

USCA11 Case: 21-11269     Date Filed: 08/03/2022   Page: 1 of 17

                                           [DO NOT PUBLISH]
                            In the
         United States Court of Appeals
                 For the Eleventh Circuit

                   ____________________

                         No. 21-11269
                   Non-Argument Calendar
                   ____________________

UNITED STATES OF AMERICA,
                                              Plaintiff-Appellee,
versus
IRVING CEPEDA-CHICO,

                                           Defendant-Appellant.

                   ____________________

          Appeal from the United States District Court
               for the Middle District of Florida
          D.C. Docket No. 6:19-cr-00217-GAP-LRH-1
                   ____________________
USCA11 Case: 21-11269          Date Filed: 08/03/2022   Page: 2 of 17

2                      Opinion of the Court                 21-11269

Before WILSON, BRANCH, and ANDERSON, Circuit Judges.
PER CURIAM:
       Irving Cepeda-Chico appeals his 168-month sentence after
pleading guilty to one count of conspiring to distribute and possess
with intent to distribute fentanyl and twelve counts of distributing
and possessing with intent to distribute heroin and fentanyl. He
argues on appeal that: (1) there was insufficient evidence to support
the district court’s upward departure under U.S.S.G. § 5K2.1;
(2) the district court failed to state sufficient reasons for its
departure, as required by 18 U.S.C. § 3553(c)(2); and (3) his
sentence is procedurally and substantively unreasonable. After
review, we affirm.
                          I.       Background
       In October 2019, Cepeda-Chico was charged with one count
of distributing a controlled substance containing a detectable
amount of fentanyl, which resulted in the death of M.D. on July 19,
2019. Thereafter, the government filed a superseding indictment
that did not contain the initial charge, but instead contained 13
counts—one for conspiracy to distribute and possess with intent to
distribute fentanyl and twelve for distributing and possessing with
intent to distribute heroin. Cepeda-Chico pleaded guilty to all
thirteen counts, pursuant to a written plea agreement. According
to the factual basis in the plea agreement, between December 2018
and July 2019, Cepeda-Chico purchased heroin and fentanyl-laced
USCA11 Case: 21-11269       Date Filed: 08/03/2022   Page: 3 of 17

21-11269              Opinion of the Court                       3

heroin from a supplier in Mexico and distributed the drugs to
various individuals in Florida, including an undercover informant
and a man named M.D. In late June 2019, police recorded a call in
which Cepeda-Chico spoke with his Mexican-based drug supplier
and told him that the batch of heroin he received from the supplier
“was not good and was burning his customers in their veins.”
Cepeda-Chico and his supplier arranged for an unnamed buyer to
buy the rest of Cepeda-Chico’s bad batch.
       On July 18, 2019, Cepeda-Chico met with M.D. and sold him
heroin. M.D. checked into the hospital later that same day for a
chronic condition, and he died overnight from ingesting a mixture
of fentanyl and heroin. Two bags of drugs were discovered on the
scene, one of which contained 3.76 grams of a mixture of fentanyl
and heroin and the other contained about half a gram of pure
heroin.
      Upon Cepeda-Chico’s arrest, he turned over several baggies
of drugs to the police—one contained 198.8 grams of fentanyl-
heroin, another 33.64 grams of heroin, and another 99.8 grams of
fentanyl-heroin.
       Cepeda-Chico’s resulting guidelines range was 120 months’
imprisonment—the statutory mandatory minimum. He faced a
statutory maximum term of life. The United States Probation
Office identified M.D.’s death as a potential ground for departure
under U.S.S.G. § 5K2.1.
USCA11 Case: 21-11269      Date Filed: 08/03/2022    Page: 4 of 17

4                     Opinion of the Court               21-11269

       The government filed a motion for an eight-level upward
departure under U.S.S.G. § 5K2.1, arguing that Cepeda-Chico
engaged in the prolonged, wide-spread distribution of
fentanyl-laced heroin, in disregard of the known dangers from
fentanyl, which resulted in M.D.’s death. Cepeda-Chico opposed
the motion, arguing that the government could not meet its
burden to prove by a preponderance of the evidence that he
supplied the drugs that resulted in M.D.’s death. He asserted that
M.D. had a life-long history of intravenous drug abuse that was so
bad that his forearm was disfigured due to a bone infection. He
maintained that M.D. procured drugs wherever he could get them,
and that there was no direct evidence linking Cepeda-Chico to the
drugs that killed M.D. Cepeda-Chico requested a 120-month
sentence.
        At sentencing, in support of its motion for an upward
departure, the government called several witnesses. Christopher
DeLotte, the Drug Enforcement Agency (DEA) case agent,
testified that he monitored Cepeda-Chico’s phone from June 20,
2019 through August 6, 2019. In late June, Cepeda-Chico contacted
his drug supplier in Mexico because the drugs were burning
customers’ veins. The two discussed mixing fentanyl with the
heroin to try and fix the problem. Cepeda-Chico told his supplier
that if something went wrong, he was “screwed.”
        During one of the monitored calls, Cepeda-Chico arranged
to sell five grams of heroin to M.D., and law enforcement arrested
USCA11 Case: 21-11269       Date Filed: 08/03/2022   Page: 5 of 17

21-11269              Opinion of the Court                       5

M.D. during a traffic stop following the transaction on June 21,
2019.
       M.D. was released from jail on the night of July 17, 2019,
into the custody of his mother. The next day, M.D.’s mother drove
him to meet Cepeda-Chico at a Walgreens because he stated that
he owed Cepeda-Chico money for the June purchase of drugs.
Surveillance footage from the Walgreens showed M.D. meeting
with Cepeda-Chico inside Cepeda-Chico’s vehicle. Cepeda-Chico
admitted to law enforcement that he sold 3 grams of heroin to
M.D. at the Walgreens and that M.D. was his best customer.
Cepeda-Chico told law enforcement that he received a call from
M.D. later that evening, and M.D. told him that the heroin was
“garbage.”
      On July 19, 2019, DeLotte learned that M.D. died of a drug
overdose while in the hospital for a chronic condition. In M.D.’s
hospital room, police found two bags of drugs—one containing just
heroin and one containing a mixture of heroin and fentanyl, a
spoon, and a syringe containing heroin and fentanyl.
       On cross-examination, DeLotte testified that M.D.’s mother
told him that M.D. would also sometimes buy drugs while in Las
Vegas. He extracted data from M.D.’s phone, but he did not recall
finding information suggesting that M.D. bought heroin from
anyone other than Cepeda-Chico. M.D.’s mother picked up M.D.
from jail, took M.D. to the hospital, and stated that M.D. was with
her the entire time. Based on Cepeda-Chico’s statement that he
sold heroin to M.D. just prior to M.D.’s overdose, DeLotte
USCA11 Case: 21-11269      Date Filed: 08/03/2022    Page: 6 of 17

6                     Opinion of the Court               21-11269

believed that the drug’s Cepeda-Chico sold to M.D. resulted in
M.D.’s death. DeLotte confirmed that M.D. was facing a
mandatory-minimum sentence for the drug charge stemming from
his June arrest, and he had told his mother he was not going to go
back to jail.
       Testimony was presented that DNA testing on the baggies
of drugs discovered in M.D.’s hospital room revealed two DNA
profiles—98% from M.D. and 2% from an unknown contributor—
and that Cepeda-Chico was excluded as a contributor. The
laboratory analyst confirmed that individuals do not necessarily
leave DNA on every surface they touch, and an individual’s DNA
could appear on an object they have not touched through
“secondary transfer” if that individual interacted with someone
who later touched that object.
        Dr. Marie Hansen, the medical examiner for M.D.’s case,
testified that M.D.’s death was the result of “[t]he combined
toxicity of fentanyl and heroin.” M.D. had a “very small amount
of heroin” present in his system, and “more than three times the
amount [of fentanyl] that you would expect to put somebody
under for surgery.” M.D. was given a therapeutic dose of
morphine at midnight by hospital staff, but Dr. Hansen did not
believe it contributed to M.D.’s death. Dr. Hansen opined that
M.D. most likely would not have died without the fentanyl.
       Claudia Beache, M.D.’s mother, testified that M.D. had used
drugs for over 20 years, and Cepeda-Chico was his main source of
drugs because he felt confident in the heroin that Cepeda-Chico
USCA11 Case: 21-11269       Date Filed: 08/03/2022    Page: 7 of 17

21-11269               Opinion of the Court                       7

sold him. She sometimes drove M.D. to these drug transactions
because she did not feel it was safe for him to drive. She picked
M.D. up outside the jail on the evening of June 17, 2019, they
returned home, he slept most of the next morning and then helped
her with a few chores, and they left the afternoon of June 18, 2019,
to go to the hospital. She confirmed that he never left the home
before they left for the hospital. Before they went to the hospital,
M.D. had her take him to an ATM because he stated he owed
money to Cepeda-Chico for the drugs he bought in June, and they
met Cepeda-Chico at a Walgreens. After meeting with Cepeda-
Chico and picking up food at a nearby fast-food restaurant, they
went to the hospital, M.D. was admitted, and Beache left the
hospital shortly before 10:00 p.m. On cross-examination, she
confirmed that M.D. was facing a possible three-year mandatory-
minimum sentence for his June arrest, and M.D. told her that he
did not want to go back to jail.
      M.D.’s sister testified that she talked with him about
fentanyl issues, but that he stated that he was not concerned
because he knew the product that he was getting from
Cepeda-Chico. After M.D.’s death, she found an unread text from
Cepeda-Chico asking if M.D. was “ready for another batch,” but
she deleted Cepeda-Chico’s text because she did not want her
mother to see it.
      Following the government’s witnesses, Cepeda-Chico’s
counsel argued that an upward departure was not appropriate
because the government had not proved by a preponderance of the
USCA11 Case: 21-11269       Date Filed: 08/03/2022     Page: 8 of 17

8                      Opinion of the Court                21-11269

evidence that the drugs Cepeda-Chico sold M.D. were the drugs
that killed him. He pointed out that two baggies of drugs were
found in M.D.’s hospital room, and argued that Cepeda-Chico gave
M.D. the one with pure heroin, not the one with the mixture of
fentanyl and heroin that killed M.D. He also emphasized that
Cepeda-Chico’s DNA was not found on either of the baggies.
       With regard to the 18 U.S.C. § 3553(a) sentencing factors,
Cepeda-Chico’s counsel emphasized that Cepeda-Chico grew up in
a small, poor town in Puerto-Rico and was raised primarily by his
mother. Cepeda-Chico had two young children and was going to
miss their formative years. Counsel emphasized that Cepeda-
Chico cooperated with law enforcement as soon as he was
arrested, was very remorseful, and was not a danger to the public.
Counsel argued that M.D. “knew what he was doing” and did not
intend to go back to jail, and that Cepeda-Chico should not be held
responsible for M.D.’s choice.
       The government argued that Cepeda-Chico distributed
large quantities of drugs for a living, and he had to be held
accountable for that as well as for what happened to M.D. The
government emphasized Cepeda-Chico’s conversations with his
supplier about the bad batch of heroin and that they discussed
mixing fentanyl with it. The government argued that an eight-level
upward departure was warranted because it reflected the offense
level that Cepeda-Chico would have received had he been
convicted of distributing drugs containing fentanyl, which resulted
in the death of another. The district court recessed so that it could
USCA11 Case: 21-11269        Date Filed: 08/03/2022    Page: 9 of 17

21-11269               Opinion of the Court                        9

consider all the evidence and allowed the parties to submit
supplemental briefs.
        Approximately six weeks later, the sentencing hearing
resumed. The district court explained that it had reviewed the
transcripts, exhibits, and filings by the parties, and it found “that
the illegal substance sold by the defendant to Mr. Dozier on July
18th was the cause of his death,” but determined that the eight-
level upward departure requested by the government was not
appropriate. Rather, it concluded that a six-level upward departure
was appropriate under the circumstances because “Cepeda-Chico
did sell a substance containing fentanyl, which led to the death of a
human being, and that is definitely a game changer when it comes
to drug sentencing.” With the upward departure, Cepeda-Chico’s
new guidelines range was 168 to 210 months’ imprisonment. The
district court noted that it considered the § 3553(a) factors and
imposed a sentence of 168 months’ imprisonment, followed by five
years of supervised release. Cepeda-Chico stated he had no
objections to the sentence or the manner in which it was
pronounced. Cepeda-Chico timely appealed.
                           II.    Discussion
   A. Whether the district court erred in applying the U.S.S.G.
      § 5K2.1 and upwardly departing from the guidelines range
        Cepeda-Chico argues that the there was insufficient
evidence to support the U.S.S.G. § 5K2.1 enhancement, and the
district court clearly erred in finding that Cepeda-Chico supplied
USCA11 Case: 21-11269       Date Filed: 08/03/2022     Page: 10 of 17

10                     Opinion of the Court                 21-11269

the drugs that killed M.D. He maintains that he only sold M.D. one
bag of pure heroin on July 18, 2019, and that the government failed
to present any direct evidence that linked him with the bag of the
fentanyl-heroin mixture, noting that it had DNA from an unknown
individual on it. He also asserts that testimony established that he
sold M.D. pure heroin in the past, and that M.D. sometimes bought
drugs elsewhere when he was out of town. He argues that only
mere speculation supports the district court’s finding that he sold
M.D. the drugs that resulted in his death.
       We review the district court’s interpretation and application
of the Sentencing Guidelines de novo and its factual findings for
clear error. United States v. Little, 864 F.3d 1283, 1290 (11th Cir.
2017). We review the district court’s decision to grant an upward
departure for an abuse of discretion. United States v. Flanders, 752
F.3d 1317, 1341 (11th Cir. 2014). “For a factual finding to be clearly
erroneous, this Court, after reviewing all the evidence, must be left
with a definite and firm conviction that a mistake has been
committed.” Little, 864 F.3d at 1290 (quotation omitted). A factual
finding cannot be clearly erroneous where the district court
chooses between two permissible views of the evidence. United
States v. Wilson, 788 F.3d 1298, 1317 (11th Cir. 2015).
       The sentencing guidelines provide that the district court
may depart from the guidelines range for certain reasons, including
if death resulted from the defendant’s conduct. U.S.S.G. §§ 5K2.0,
5K2.1. Among other things, the extent of the departure depends
“on the dangerousness of the defendant’s conduct, the extent to
USCA11 Case: 21-11269      Date Filed: 08/03/2022    Page: 11 of 17

21-11269              Opinion of the Court                      11

which death or serious injury was intended or knowingly risked,
and the extent to which the offense level for the offense of
conviction, as determined by the other Chapter Two guidelines,
already reflects the risk of personal injury.” Id. § 5K2.1.
       The district court’s finding that Cepeda-Chico sold M.D. the
drugs that resulted in M.D.’s death was not clearly erroneous. The
evidence presented at sentencing indicated that between M.D.’s
release from jail late on the evening of July 17, 2019, and his
admission to the hospital on the evening of July 18, 2019, he was
with his mother the entire time, and his mother drove him to meet
with Cepeda-Chico on the afternoon of July 18. Cepeda-Chico
admitted that he sold heroin to M.D. that day. A few hours later,
M.D. overdosed in the bathroom of his hospital room in the early
morning hours of July 19. And Cepeda-Chico had conversations in
late June 2019 with his drug supplier about mixing fentanyl with a
batch of heroin to prevent it from burning customers’ veins. Based
on the totality of the evidence, the district court could have
reasonably inferred that Cepeda-Chico sold M.D. the drugs that
resulted in his death.
       The lack of Cepeda-Chico’s touch DNA on the baggies of
drugs found with M.D. and the presence of a very small amount of
touch DNA from an unknown person on the baggies does not
necessarily undermine the conclusion that Cepeda-Chico sold
M.D. the drugs in question. The laboratory technician testified
that a person does not always leave DNA when he touches an item
and that there is a possibility of secondary touch DNA transfer.
USCA11 Case: 21-11269          Date Filed: 08/03/2022       Page: 12 of 17

12                       Opinion of the Court                    21-11269

The evidence was therefore sufficient to meet the government’s
burden to prove by a preponderance of the evidence that M.D.’s
death resulted from an overdose of the drugs he purchased from
Cepeda-Chico.1 Accordingly, the district court did not abuse its
discretion in applying § 5K2.1 and upwardly departing from the
guidelines range.
     B. Whether the district court sufficiently stated its reasons for
        the upward departure

       Cepeda-Chico argues that the district court failed to provide
specific reasons in open court for the upward departure, in
violation of 18 U.S.C. 3553(c)(2).
        If a district court departs from the guidelines range, it must
state in open court at sentencing and in a statement of reasons form
“the specific reason for the imposition of a sentence” outside the
guidelines range. 18 U.S.C. § 3553(c)(2); U.S.S.G. § 5K2.0(e).
“[T]he district court’s reasons must be sufficiently specific so that
an appellate court can engage in the meaningful review envisioned
by the Sentencing Guidelines.” United States v. Parks, 823 F.3d
990, 997 (11th Cir. 2016) (quotation omitted). In other words, the
district court must “answer the key question of why [it] imposed
an above-guideline sentence.” Id. “If the court does not do this,

1
  Although there may have been a permissible view of the evidence that
supports Cepeda-Chico’s position, a factual finding is not clearly erroneous
where the district court chooses between two permissible views of the
evidence. Wilson, 788 F.3d at 1317.
USCA11 Case: 21-11269        Date Filed: 08/03/2022     Page: 13 of 17

21-11269                Opinion of the Court                        13

the case must be remanded for resentencing.” Id. at 997 (quotation
omitted). We review de novo whether the district court complied
with § 3553(c)(2), even if the defendant failed to object below. Id.
at 996–97.
        Here, the district court stated in open court and on the
statement of reasons form “the specific reason for the imposition
of a sentence”—namely, that Cepeda-Chico sold M.D. the drugs
that resulted in M.D.’s death. See 18 U.S.C. § 3553(c)(2). That
explanation was sufficient to enable us to engage in meaningful
appellate review of the upward departure. See United States v.
Delvecchio, 920 F.2d 810, 813 (11th Cir. 1991) (explaining that the
district court must provide a statement of reasons under
§ 3553(c)(2) “so that the reviewing court can determine whether
the departure was justified”). Although Cepeda-Chico argues that
the district court should have expounded on its reasoning further
and explained in detail the factors it considered, we do not expect
a district court “to articulate [its] findings and reasoning with great
detail.” United States v. Irey, 612 F.3d 1160, 1195 (11th Cir. 2010)
(en banc). Because the district court provided the specific reason
for the departure and we were able to conduct meaningful review
of its decision, there was no error.
   C. Whether Cepeda-Chico’s sentence is procedurally and
      substantively reasonable
        Cepeda-Chico argues that the district court imposed a
procedurally unreasonable sentence because its “rote recitation”
that it considered the 18 U.S.C. § 3553(a) factors was insufficient to
USCA11 Case: 21-11269             Date Filed: 08/03/2022           Page: 14 of 17

14                          Opinion of the Court                         21-11269

show that it actually considered the § 3553(a) factors. He also
argues that his sentence is substantively unreasonable because the
district court did not consider mitigating aspects of his background
and the offense conduct, such as his post-arrest cooperation and
favorable letters from friends.
        Generally, we review a sentence for both procedural and
substantive reasonableness under a deferential abuse of discretion
standard. See Gall v. United States, 552 U.S. 38, 51 (2007). A
sentence can be procedurally unreasonable if the district court
“fail[s] to consider the § 3553(a) factors.” Id. However, where as
here, the defendant did not object to the procedural reasonableness
of his sentence, we review his procedural reasonableness challenge
for plain error. United States v. Vandergrift, 754 F.3d 1303, 1307
(11th Cir. 2014). 2
       To establish plain error, Cepeda-Chico must show “(1) that
the district court erred; (2) that the error was plain; and (3) that the

2
 In Holguin-Hernandez v. United States, 140 S. Ct. 762, 766–67 (2020), the
Supreme Court held that where a defendant advocates for a particular
sentence in the district court, he preserves a challenge to the substantive
reasonableness of his sentence. However, the Supreme Court expressly
declined to address what is sufficient to preserve a procedural challenge. Id.
at 767; see also id. at 767 (“[W]e do not decide what is sufficient to preserve a
claim that a trial court used improper procedures in arriving at a chosen
sentence. . . . Nevertheless, as we have previously explained, failing to object
at all to a procedural error . . . will subject a procedural challenge to plain-error
review.” (quotation omitted) (Alito, J., concurring)). Therefore, Vandergrift
remains good law.
USCA11 Case: 21-11269        Date Filed: 08/03/2022      Page: 15 of 17

21-11269                Opinion of the Court                         15

error affected his substantial rights. If all three conditions are met,
we then decide whether the error seriously affected the fairness,
integrity, or public reputation of judicial proceedings.” Id.
(alterations adopted) (quotations and internal citations omitted).
He bears the burden of showing that the sentence is procedurally
unreasonable. United States v. Hill, 783 F.3d 842, 844 (11th Cir.
2015).
       We examine whether a sentence is substantively reasonable
in light of the totality of the circumstances. Gall, 552 U.S. at 51.
The district court must issue a sentence that is “sufficient, but not
greater than necessary” to comply with the purposes of 18 U.S.C.
§ 3553(a)(2), which include the need for a sentence to reflect the
seriousness of the offense, promote respect for the law, provide just
punishment, deter criminal conduct, and protect the public from
future criminal conduct. 18 U.S.C. § 3553(a). The court must also
consider the “nature and circumstances of the offense and the
history and characteristics of the defendant.” Id. § 3553(a)(1).
“[T]he district court need only ‘acknowledge’ that it considered the
§ 3553(a) factors, and need not discuss each of these factors . . . .”
United States v. Amedeo, 487 F.3d 823, 833 (11th Cir. 2007)
(quotation and internal citation omitted). Importantly, the weight
given to a particular § 3353(a) factor “is committed to the sound
discretion of the district court,” and it is not required to give “equal
weight” to the § 3553(a) factors. United States v. Rosales-Bruno,
789 F.3d 1249, 1254 (11th Cir. 2015) (quotation omitted).
USCA11 Case: 21-11269        Date Filed: 08/03/2022     Page: 16 of 17

16                      Opinion of the Court                 21-11269

       The burden rests on the party challenging the sentence to
show “that the sentence is unreasonable in light of the entire
record, the § 3553(a) factors, and the substantial deference afforded
sentencing courts.” Id. at 1256. We will “vacate the sentence if,
but only if, we are left with the definite and firm conviction that
the district court committed a clear error of judgment in weighing
the § 3553(a) factors by arriving at a sentence that lies outside the
range of reasonable sentences dictated by the facts of the case.”
Irey, 612 F.3d at 1190 (en banc) (quotation omitted).
        Cepeda-Chico cannot show that any procedural error
occurred, much less a plain error. In imposing Cepeda-Chico’s
sentence, the district court stated that it had reviewed the parties’
filings, the PSI, the evidence presented at the sentencing hearing,
and the § 3553(a) factors. The district court was not required to
discuss each factor. Amedeo, 487 F.3d at 833; see also Irey, 612 F.3d
at 1195 (en banc). Instead, “an acknowledgement that the district
court has considered the defendant’s arguments and the § 3553(a)
factors [is sufficient].” United States v. Taylor, 997 F.3d 1348, 1354–
55 (11th Cir. 2021) (alterations adopted) (quotation omitted).
      Similarly, Cepeda-Chico cannot show that the district court
abused its discretion in imposing a substantively unreasonable
sentence. Although he quarrels with how the district court
weighed the relevant factors, the weight to be accorded any given
§ 3553(a) factor is a matter committed to the sound discretion of
the district court. Rosales-Bruno, 789 F.3d at 1254 (quotation
omitted). The district court was entitled to give more weight to
USCA11 Case: 21-11269      Date Filed: 08/03/2022    Page: 17 of 17

21-11269               Opinion of the Court                      17

the nature and circumstances of the offense and M.D.’s death over
Cepeda-Chico’s mitigating circumstances. See id. at 1256.
Moreover, his total 168-month sentence is well below the statutory
maximum life, which is an indicator of reasonableness. See United
States v. Gonzalez, 550 F.3d 1319, 1324 (11th Cir. 2008) (explaining
that a sentence that is below the statutory maximum is another
indicator of reasonableness).
      Accordingly, we conclude that Cepeda-Chico’s total
168-month sentence is both procedurally and substantively
reasonable, and we affirm.
      AFFIRMED.